Investing.com··David WagnerModerna's $2.25B Settlement Clears Patent Cloud as Biotech Sector Eyes Deep Value Opportunities
Moderna settles $2.25B patent dispute, surges 15.99%. Analysis identifies 9 biotech stocks trading 27-65% below fair value with 31-251% upside potential.
MRNAROIVABUSfair valueundervalued